Picture of SynAct Pharma AB logo

SYNACT SynAct Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Synact Pharma Appoints Jeppe Øvlesen As CEO

March 20 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * SYNACT PHARMA APPOINTS JEPPE ØVLESEN CEO
    * JEPPE ØVLESEN WAS APPOINTED AS NEW CEO SUCCEEDING TORBJØRN
BJERKE EFFECTIVE IMMEDIATELY DUE TO A DISAGREEMENT OVER STRATEGY
    * FROM 2015 TO 2023 ØVLESEN WAS CEO OF SYNACT PHARMA

Source text for Eikon:  ID:nMFN4BH20W 
Further company coverage:  SYNACT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on SynAct Pharma AB

See all news